@FierceBiotech: Assessing the crowd effect on biopharma's risky R&D strategy. More | Follow @FierceBiotech
@JohnCFierce: Bristol-Myers picks up another "breakthrough" trophy in hep C cocktail showdown. News | Follow @JohnCFierce
@DamianFierce: As Big Pharma sells/spins out its animal health ops, Lily buys one. Release | Follow @DamianFierce
@EmilyMFierce: Gene therapy regenerates damaged tissue in pigs after heart attack. Story | Follow @EmilyMFierce
> Bayer is wrapping up its $2.9 billion deal to acquire Norway's Algeta. Story
> The FDA has pushed back the PDUFA date on Salix Pharmaceuticals' ($SLXP) Ruconest for hereditary angioedema by three months. Release
> KV Pharmaceutical ($KV.A) has created two new divisions under its reorganization. Story
> Just a year after his appointment, Brisbane-based Alchemia CEO Charles Walker has left the company. He's being replaced by Thomas Liquard. Report
@FierceMedDev: German study backs a Japanese firm's dissolving stent over the bare metal variety. Story | Follow @FierceMedDev
@MichaelGFierce: Capsule Tech launches a medical device integration system with a few big partners. More | Follow @MichaelGFierce
@EmilyWFierce: 3-D printing technology could be used to construct human organs, say scientists. Article | Follow @EmilyWFierce
@GalenMoore: Startup Constant Therapy raises seed funds for its iPad-based brain injury treatment. More | Follow @GalenMoore
> Endo is stocking up at least $520M to cover vaginal mesh lawsuit legal costs. Story
> Boston Scientific partners up to push Parkinson's tech in Europe. Article
Pharma News
@FiercePharma: With Teva's Symbicort copy nearing EU launch, AstraZeneca preps for battle. Story | Follow @FiercePharma
@TracyStaton: Top story at FiercePharma over weekend: FDA moves toward major overhaul in the way it approves OTC meds. More | Follow @TracyStaton
@EricPFierce: GSK could get some financial breathing room with an EU nod for Anoro. Report | Follow @EricPFierce
@CarlyHFierce: Vertex eyes another $45 million in sales as FDA swells Kalydeco's patient pool. News | Follow @CarlyHFierce
> Will the generics M&A surge put Teva on the takeover table? Investors think so. Article
> Pfizer closes in on $1B-plus sales boost for Prevnar 13 vaccine. Story
> The FDA is quietly testing some drugs for generic equivalency. Piece
CRO News
> Medpace changes hands for $915M as private equity smiles on CROs. News
> After soaring 20% in 2013, Icon eyes a bigger share of the CRO market. Article
> Quintiles lends its sequencing skills to massive cardiovascular study. Story
> Parexel expands its regulatory reach with latest move. News
> PPD partners up to give Germany a starring role in clinical trials. Story
> Charles River amps up its biologics testing. Item
Biotech IT News
> Buzz: BGI is preparing for a $400M Hong Kong IPO in Q4. Report
> U.K. delays patient database project following public backlash. News
> Roche mulls sharing Avastin trial data to clear up possible statistical quirk. Story
> U.S. team taps supercomputer to accelerate genome data analysis. Article
> Merge prepares to defend itself against fake contract lawsuits. News
> Pfizer CEO begins contributing to LinkedIn's publishing platform. Brief